Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | FNTA | P49354 | 1/20 | 0.31 |
| ▸ | FNTB | P49356 | 1/20 | 0.31 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.31 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.31 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.31 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.31 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.31 |
| ▸ | GRIK5 | Q16478 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1127391 | 0.75 | TDP1 (0.36) | ALDH1A1FFAR3TDP1THRBFNTA | |
| SCHEMBL1127385 | 0.75 | TDP1 (0.36) | ALDH1A1FFAR3TDP1THRBFNTA | |
| SCHEMBL6265353 | 0.73 | ALDH1A1 (0.35) | ALDH1A1FFAR3TDP1THRBFNTA | |
| SCHEMBL5143664 | 0.73 | FFAR3 (0.35) | ALDH1A1FFAR3TDP1THRBFNTA | |
| SCHEMBL10707630 | 0.72 | EPHX1 (0.39) | EPHX1ALDH1A1FFAR3 | |
| SCHEMBL11751968 | 0.72 | EPHX1 (0.39) | EPHX1ALDH1A1FFAR3 | |
| SCHEMBL1509770 | 0.70 | EPHX1 (0.34) | EPHX1ALDH1A1FFAR3TDP1KDM4C | |
| SCHEMBL125890 | 0.70 | EPHX1 (0.34) | EPHX1ALDH1A1FFAR3TDP1THRB | |
| SCHEMBL526285 | 0.70 | EPHX1 (0.34) | EPHX1ALDH1A1FFAR3TDP1THRB | |
| SCHEMBL101165 | 0.69 | FFAR3 (0.53) | ALDH1A1FFAR3TDP1THRBFNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4547288-A1 | RADIOPAQUE MONOMER AND EMBOLISATION MICROSPHERES COMPRISING SAME | Guerbet (FR) | 2025-05-07 | — | — | EP | claimed |
| WO-2024003184-A1 | RADIOPAQUE MONOMER AND EMBOLISATION MICROSPHERES COMPRISING SAME | GUERBET (FR) | 2024-01-04 | — | — | WO | claimed |
| EP-4299080-A1 | RADIO-OPAQUE MONOMER AND EMBOLISATION MICROSPHERES COMPRISING SAME | Guerbet (FR) | 2024-01-03 | — | — | EP | claimed |
| US-20230285601-A1 | NON DEGRADABLE RADIO-OPAQUE EMBOLISATION MICROSPHERE | GUERBET (FR) | 2023-09-14 | — | — | US | claimed |
| US-20230272142-A1 | NON-DEGRADABLE EMBOLISATION MICROSPHERE | GUERBET (FR) | 2023-08-31 | — | — | US | claimed |
| EP-4041318-A1 | NON-DEGRADABLE EMBOLISATION MICROSPHERE | Guerbet (FR) | 2022-08-17 | — | — | EP | claimed |
| WO-2021069527-A1 | NON-DEGRADABLE EMBOLISATION MICROSPHERE | GUERBET (FR) | 2021-04-15 | — | — | WO | claimed |
| EP-2683750-B1 | IMPLANTABLE SWELLABLE BIO-RESORBABLE POLYMER | OCCLUGEL (FR) | 2017-04-19 | — | — | EP | claimed |
| EP-2683753-B1 | IMPLANTABLE BIO-RESORBABLE POLYMER CHARGED WITH FRAGILE MACROMOLECULES | OCCLUGEL (FR) | 2016-08-03 | — | — | EP | claimed |
| US-20130344159-A1 | IMPLANTABLE SWELLABLE BIO-RESORBABLE POLYMER | OCCLUGEL (FR) | 2013-12-26 | — | — | US | claimed |
| US-20120230937-A1 | IMPLANTABLE BIO-RESORBABLE POLYMER | OCCLUGEL (FR) | 2012-09-13 | — | — | US | claimed |
| WO-2011029867-A1 | IMPLANTABLE BIO-RESORBABLE POLYMER | OCCLUGEL (FR) | 2011-03-17 | — | — | WO | claimed |
| EP-2295480-A1 | Implantable bio-resorbable polymer | Occlugel (FR) | 2011-03-16 | — | — | EP | claimed |
| US-12552891-B2 | Non-degradable embolisation microsphere | GUERBET (FR) | 2026-02-17 | — | — | US | disclosed |
| EP-4547288-A1 | RADIOPAQUE MONOMER AND EMBOLISATION MICROSPHERES COMPRISING SAME | Guerbet (FR) | 2025-05-07 | — | — | EP | disclosed |
| US-20240018396-A1 | LOW TEMPERATURE ACTIVATED RELEASE COATING AND A METHOD OF MAKING | 3M INNOVATIVE PROPERTIES COMPANY | 2024-01-18 | — | — | US | disclosed |
| EP-0020614-A4 | METHOD FOR COATING A POLYCARBONATE ARTICLE WITH SILICA FILLED ORGANOPOLYSILOXANE. | GEN ELECTRIC (US) | 1981-03-24 | — | — | EP | disclosed |
| EP-0020614-A1 | METHOD FOR COATING A POLYCARBONATE ARTICLE WITH SILICA FILLED ORGANOPOLYSILOXANE. | GEN ELECTRIC (US) | 1981-01-07 | — | — | EP | disclosed |
| US-4207357-A | PRIMING WITH THERMOSETTING ACRYLIC POLYMER | GENERAL ELECTRIC COMPANY (US) | 1980-06-10 | — | — | US | disclosed |
| WO-1980000969-A1 | METHOD FOR COATING A POLYCARBONATE ARTICLE WITH SILICA FILLED ORGANOPOLYSILOXANE | GEN ELECTRIC (US) | 1980-05-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552891-B2 | Non-degradable embolisation microsphere | VEGFA, FGB, MSR1 | EPHX1 354/4885ALDH1A1 2132/4885FFAR3 1056/4885 |
| US-20130344159-A1 | IMPLANTABLE SWELLABLE BIO-RESORBABLE POLYMER | CRKL, CMKLR1, BMPR1A | EPHX1 1812/4885ALDH1A1 4108/4885FFAR3 635/4885 |
| US-20120230937-A1 | IMPLANTABLE BIO-RESORBABLE POLYMER | PTH1R, BMP2, BMPR1A | EPHX1 2250/4885ALDH1A1 3729/4885FFAR3 464/4885 |
| US-20230285601-A1 | NON DEGRADABLE RADIO-OPAQUE EMBOLISATION MICROSPHERE | KIT, TIE1, HRH4 | EPHX1 170/4885ALDH1A1 2525/4885FFAR3 251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.